Investors & Media
News feed

2019
  • 16 October 2019
    Selvita and Ryvu Therapeutics Announce Independent Trading
    on the Warsaw Stock Exchange
  • 01 October 2019
    Ryvu Therapeutics and Selvita Announce registration of Corporate Split by the National Court Register of Poland
  • 19 September 2019
    Selvita announces shareholder approval of corporate split and new name of Ryvu Therapeutics for oncology development company
  • 09 September 2019
    Polish Financial Supervision Authority approves Selvita Cro prospectus, allowing corporate split into two separately listed companies to proceed
  • 28 March 2019
    Selvita to separate oncology therapeutics and contract research business units into two global companies
selvita_logo